Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)ByRobert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD,Brenda Motheral, PhD,Doug Mager, BSApril 1st 2004
Verification of a Decision Analytic Model Assumption Using Real-World Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)ByEmily R. Cox, PhD,Brenda Motheral, PhD,Doug Mager, BSDecember 1st 2003
Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition TherapyByEmily R. Cox, PhD,Brenda Motheral, PhD,Mark Frisse, MD*,Andrew Behm, PharmD,Doug Mager, BSNovember 1st 2003
